Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Depression News

The Devastating Effects Of Depression When It Accompanies A Chronic Disease

rate icon Featured Article
Main Category: Depression
Also Included In: Diabetes;  Arthritis / Rheumatology;  Respiratory / Asthma
Article Date: 07 Sep 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:5 stars

4.82 (17 votes)

Health Professional:4 and a half stars

4.38 (8 votes)

Article Opinions: 1 posts

The damage that co-morbid depression has on a patient's health is greater than that caused by such chronic illnesses as diabetes, angina, asthma and arthritis, according to an article published in The Lancet. In other words, depression with diabetes is more damaging than diabetes with angina or asthma or arthritis.

Dr Somnath Chatterji, World Health Organisation (WHO), Geneva, Switzerland and team looked at data on 245,404 people from the World Health Survey (WHO). They discovered that the prevalence of a depressive episode during the previous year was 3.2% - for diabetes this figure was 2%, for arthritis 4.1%, for angina 5.4% and for asthma 3.3%.

They found that a large number of people had one or more of these chronic diseases as well as depression - between 9% to 23% of them.

They found that depression has the largest effect on worsening health compared with the other listed chronic illnesses, even after adjustments were made for socioeconomic factors and health conditions. Depression, accompanied by one or more chronic disease(s) gave patients the worst health scores - these scores did not alter much from country to country around the globe.

"The co-morbid state of depression incrementally worsens health compared with depression alone, with any of the chronic diseases alone, and with any combination of chronic diseases without depression. These results indicate the urgency of addressing depression as a public health priority to reduce disease burden and disability, and to improve the overall health of populations," the authors wrote.

An accompanying Comment pointed out that while 80% of patients with arthritis and 90% of patients with asthma receive an acceptable standard of care, the case is nowhere near the same for depression. "In Australia, less than 30% of patients receive good treatment with anti-depressants, cognitive behavioural therapy, and proactive maintenance care. Perhaps differential access to treatment is one reason why disability is less with the physical disorders. Treatment for depression should at least be on a par with that for other chronic diseases." The Comment was written by Professor Gavin Andrews and Dr Nickolai Titov, Clinical Research Unit for Anxiety and Depression, University of New South Wales at St Vincent's Hospital, Sydney, Australia.

http://www.thelancet.com

Written by: Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Targacept Presents Data From Highly Successful Phase 2b Trial Of TC-5214 As Augmentation Treatment For Major Depressive Disorder
16 Oct 2009
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced the presentation of data from its recently completed Phase 2b...


Seasonal Depression image Seasonal Depression

Every winter, when the days get shorter, people with seasonal affective disorder, also known as SAD, experience depression. Learn how light can help chase away the winter blues...

Treating Major Depression image Treating Major Depression

Major depression is more than just suffering from a bad mood. It can affect just about everything you do, from how you sleep at night to how well you perform your job. Learn how you can feel better...

View more videos...